Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary

John P. Geisler, Robert Goulet, Richard Foster, Gregory P. Sutton

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: The growing teratoma syndrome has been described with regard to gonadal and extragonadal germ cell neoplasms in males, but few cases have been reported in the female population. In this condition, masses that enlarge during or after chemotherapy are found to contain mature teratoma without malignant elements. Cases: Three patients had either persistent or growing masses despite chemotherapy for germ cell malignancies of the ovary. All cases fit the description of the growing teratoma syndrome. The patients were aged 20–22 years. All three patients had immature teratomas before chemotherapy. The stages of disease ranged from la to IIIc. All patients had normal tumor markers while their masses showed growth or persistence. All were free of disease 6–31 months after diagnosis. Conclusion: Growth or persistence of a tumor after chemotherapy for malignant teratoma does not necessarily imply progression of malignancy, especially if tumor markers are normal. However, these masses should be resected because they may cause obstruction, compression, or displacement of adjacent organs, or undergo sarcomatous degeneration. (Ob-stet Gynecol 1994;84:719–21).

Original languageEnglish
Pages (from-to)719-721
Number of pages3
JournalObstetrics and Gynecology
Volume84
Issue number4
StatePublished - 1994

Fingerprint

Germ Cell and Embryonal Neoplasms
Teratoma
Ovary
Drug Therapy
Tumor Biomarkers
Neoplasms
Growth
Germ Cells
Population

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary. / Geisler, John P.; Goulet, Robert; Foster, Richard; Sutton, Gregory P.

In: Obstetrics and Gynecology, Vol. 84, No. 4, 1994, p. 719-721.

Research output: Contribution to journalArticle

Geisler, JP, Goulet, R, Foster, R & Sutton, GP 1994, 'Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary', Obstetrics and Gynecology, vol. 84, no. 4, pp. 719-721.
Geisler, John P. ; Goulet, Robert ; Foster, Richard ; Sutton, Gregory P. / Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary. In: Obstetrics and Gynecology. 1994 ; Vol. 84, No. 4. pp. 719-721.
@article{09926d5cabc246498df36d18d8590164,
title = "Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary",
abstract = "Background: The growing teratoma syndrome has been described with regard to gonadal and extragonadal germ cell neoplasms in males, but few cases have been reported in the female population. In this condition, masses that enlarge during or after chemotherapy are found to contain mature teratoma without malignant elements. Cases: Three patients had either persistent or growing masses despite chemotherapy for germ cell malignancies of the ovary. All cases fit the description of the growing teratoma syndrome. The patients were aged 20–22 years. All three patients had immature teratomas before chemotherapy. The stages of disease ranged from la to IIIc. All patients had normal tumor markers while their masses showed growth or persistence. All were free of disease 6–31 months after diagnosis. Conclusion: Growth or persistence of a tumor after chemotherapy for malignant teratoma does not necessarily imply progression of malignancy, especially if tumor markers are normal. However, these masses should be resected because they may cause obstruction, compression, or displacement of adjacent organs, or undergo sarcomatous degeneration. (Ob-stet Gynecol 1994;84:719–21).",
author = "Geisler, {John P.} and Robert Goulet and Richard Foster and Sutton, {Gregory P.}",
year = "1994",
language = "English",
volume = "84",
pages = "719--721",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary

AU - Geisler, John P.

AU - Goulet, Robert

AU - Foster, Richard

AU - Sutton, Gregory P.

PY - 1994

Y1 - 1994

N2 - Background: The growing teratoma syndrome has been described with regard to gonadal and extragonadal germ cell neoplasms in males, but few cases have been reported in the female population. In this condition, masses that enlarge during or after chemotherapy are found to contain mature teratoma without malignant elements. Cases: Three patients had either persistent or growing masses despite chemotherapy for germ cell malignancies of the ovary. All cases fit the description of the growing teratoma syndrome. The patients were aged 20–22 years. All three patients had immature teratomas before chemotherapy. The stages of disease ranged from la to IIIc. All patients had normal tumor markers while their masses showed growth or persistence. All were free of disease 6–31 months after diagnosis. Conclusion: Growth or persistence of a tumor after chemotherapy for malignant teratoma does not necessarily imply progression of malignancy, especially if tumor markers are normal. However, these masses should be resected because they may cause obstruction, compression, or displacement of adjacent organs, or undergo sarcomatous degeneration. (Ob-stet Gynecol 1994;84:719–21).

AB - Background: The growing teratoma syndrome has been described with regard to gonadal and extragonadal germ cell neoplasms in males, but few cases have been reported in the female population. In this condition, masses that enlarge during or after chemotherapy are found to contain mature teratoma without malignant elements. Cases: Three patients had either persistent or growing masses despite chemotherapy for germ cell malignancies of the ovary. All cases fit the description of the growing teratoma syndrome. The patients were aged 20–22 years. All three patients had immature teratomas before chemotherapy. The stages of disease ranged from la to IIIc. All patients had normal tumor markers while their masses showed growth or persistence. All were free of disease 6–31 months after diagnosis. Conclusion: Growth or persistence of a tumor after chemotherapy for malignant teratoma does not necessarily imply progression of malignancy, especially if tumor markers are normal. However, these masses should be resected because they may cause obstruction, compression, or displacement of adjacent organs, or undergo sarcomatous degeneration. (Ob-stet Gynecol 1994;84:719–21).

UR - http://www.scopus.com/inward/record.url?scp=0028050072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028050072&partnerID=8YFLogxK

M3 - Article

C2 - 9205463

AN - SCOPUS:0028050072

VL - 84

SP - 719

EP - 721

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -